1921
Volume 99, Issue 3
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Antibiotics improve both weight and height gain in randomized trials of preschool children with preexisting morbidity. Here, we assess the effect of a short course of three different antibiotics (amoxicillin, azithromycin, and cotrimoxazole) on short-term linear and ponderal growth in a population-based sample of preschool children in rural Burkina Faso. We randomized households with at least two children in the Nouna district, Burkina Faso, to a 5-day course of amoxicillin, azithromycin, cotrimoxazole, or placebo. Within each antibiotic-randomized household, one child was randomly assigned to receive the antibiotic and the other to receive the placebo. Weight and height measurements were taken at baseline and 30 days following the last study medication dose. Weight-for-height (WHZ), height-for-age (HAZ), and weight-for-age (WAZ) scoreswere calculated based on the 2006 World Health Organization standards. Of the 124 households and 248 children enrolled, 229 had anthropometry measurements at 1 month and were analyzed. Children randomized to amoxicillin gained significantly more weight compared with both the placebo household (mean difference 317 g, 95% confidence interval [CI]: 115–519 g) and placebo sibling (mean difference 315 g, 95% CI: 147–482 g) controls. Growth velocity in g/kg/day, and WHZ and WAZ scores were higher in amoxicillin-treated children compared with placebo households and siblings. There were no differences in weight gain in children randomized to azithromycin or cotrimoxazole compared with placebo households or placebo siblings. There were no differences in height gain or HAZ across any of the study arms. Amoxicillin may have short-term growth-promoting effects in healthy children.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.18-0342
2018-07-16
2019-07-16
Loading full text...

Full text loading...

/deliver/fulltext/14761645/99/3/tpmd180342.html?itemId=/content/journals/10.4269/ajtmh.18-0342&mimeType=html&fmt=ahah

References

  1. Black RE, Maternal and Child Nutrition Study Group , 2013. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet 382: 427451. [Google Scholar]
  2. Caulfield LE, de Onis M, Blössner M, Black RE, , 2004. Undernutrition as an underlying cause of child deaths associated with diarrhea, pneumonia, malaria, and measles. Am J Clin Nutr 80: 193198. [Google Scholar]
  3. Ginsburg AS, Izadnegahdar R, Berkley JA, Walson JL, Rollins N, Klugman KP, , 2015. Undernutrition and pneumonia mortality. Lancet Glob Health 3: e735e736. [Google Scholar]
  4. Page A-L, 2013. Infections in children admitted with complicated severe acute malnutrition in Niger. PLoS One 8: e68699. [Google Scholar]
  5. Deen JL, Walraven G, von Seidlein L, , 2002. Increased risk for malaria in chronically malnourished children under 5 years of age in rural Gambia. J Trop Pediatr 48: 7883. [Google Scholar]
  6. Denoeud-Ndam L, 2016. Efficacy of artemether-lumefantrine in relation to drug exposure in children with and without severe acute malnutrition: an open comparative intervention study in Mali and Niger. BMC Med 14: 167. [Google Scholar]
  7. Isanaka S, 2016. Routine amoxicillin for uncomplicated severe acute malnutrition in children. N Engl J Med 374: 444453. [Google Scholar]
  8. Trehan I, Goldbach HS, LaGrone LN, Meuli GJ, Wang RJ, Maleta KM, Manary MJ, , 2013. Antibiotics as part of the management of severe acute malnutrition. N Engl J Med 368: 425435. [Google Scholar]
  9. Gough EK, 2014. The impact of antibiotics on growth in children in low and middle income countries: systematic review and meta-analysis of randomised controlled trials. BMJ 348: g2267. [Google Scholar]
  10. Oldenburg CE, Guerin PJ, Berthé F, Grais RF, Isanaka S, , 2018. Malaria and nutritional status among children with severe acute malnutrition in Niger: a prospective cohort study. Clin Infect Dis Epub ahead of print, doi: 10.1093/cid/ciy207/4924398. [Google Scholar]
  11. Garrett WS, , 2013. Kwashiorkor and the gut microbiota. N Engl J Med 368: 17461747. [Google Scholar]
  12. Smith MI, 2013. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science 339: 548554. [Google Scholar]
  13. Doan T, 2017. Gut microbial diversity in antibiotic-naive children after systemic antibiotic exposure: a randomized controlled trial. Clin Infect Dis 64: 11471153. [Google Scholar]
  14. de Clercq NC, Groen AK, Romijn JA, Nieuwdorp M, , 2016. Gut microbiota in obesity and undernutrition. Adv Nutr 7: 10801089. [Google Scholar]
  15. Sie A, Louis VR, Gbangou A, Muller O, Niamba L, Stieglbauer G, M, Kouyate B, Sauerborn R, Thorson A, , 2010. The health and demographic surveillance system (HDSS) in Nouna, Burkina Faso, 1993–2007. Glob Health Action 3: 5284. [Google Scholar]
  16. Porco TC, Stoller NE, Keenan JD, Bailey RL, Lietman TM, , 2015. Public key cryptography for quality assurance in randomization for clinical trials. Contemp Clin Trials 42: 167168. [Google Scholar]
  17. Lockman S, 2017. Effect of co-trimoxazole on mortality in HIV-exposed but uninfected children in Botswana (the Mpepu Study): a double-blind, randomised, placebo-controlled trial. Lancet Glob Health 5: e491e500. [Google Scholar]
  18. WHO, 2006. Guidelines on Co-Trimoxazole Prophylaxis for HIV-Related Infections among Children, Adolescents, and Adults. Available at: http://www.who.int/hiv/pub/guidelines/ctxguidelines.pdf. Accessed June 12, 2018.
  19. Chintu C, CHAP Trial Team , 2004. Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial. Lancet 364: 18651871. [Google Scholar]
  20. Bwakura-Dangarembizi M, 2014. A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa. N Engl J Med 370: 4153. [Google Scholar]
  21. Aiemjoy K, 2018. Defining diarrhea: a population-based validation study of caregiver-reported stool consistency in the Amhara Region of Ethiopia. Am J Trop Med Hyg 98: 10131020. [Google Scholar]
  22. Scott FI, Horton DB, Mamtani R, Haynes K, Goldberg DS, Lee DY, Lewis JD, , 2016. Administration of antibiotics to children before age 2 years increases risk for childhood obesity. Gastroenterology 151: 120129. [Google Scholar]
  23. Gerber JS, Bryan M, Ross RK, Daymont C, Parks EP, Localio AR, Grundmeier RW, Stallings VA, Zaoutis TE, , 2016. Antibiotic exposure during the first 6 months of life and weight gain during childhood. JAMA 315: 12581265. [Google Scholar]
  24. Saari A, Virta LJ, Sankilampi U, Dunkel L, Saxen H, , 2015. Antibiotic exposure in infancy and risk of being overweight in the first 24 months of life. Pediatrics 135: 617626. [Google Scholar]
  25. Rogawski ET, MAL-ED Network Investigators , 2017. Early antibiotic exposure in low-resource settings is associated with increased weight in the first two years of life. J Pediatr Gastroenterol Nutr 65: 350356. [Google Scholar]
  26. Wehner S, Stieglbauer G, Traoré C, Sie A, Becher H, Muller O, , 2017. Malaria incidence during early childhood in rural Burkina Faso: analysis of a birth cohort protected with insecticide-treated mosquito nets. Acta Trop 175: 7883. [Google Scholar]
  27. Guillebaud J, 2013. Epidemiology of malaria in an area of seasonal transmission in Niger and implications for the design of a seasonal malaria chemoprevention strategy. Malar J 12: 379. [Google Scholar]
  28. Kampe EOI, Muller O, Sie A, Becher H, , 2015. Seasonal and temporal trends in all-cause and malaria mortality in rural Burkina Faso, 1998–2007. Malar J 14: 300. [Google Scholar]
  29. Belesova K, Gasparrini A, Sie A, Sauerborn R, Wilkinson P, , 2018. Annual crop yield variation, child survival, and nutrition among subsistence farmers in Burkina Faso. Am J Epidemiol 187: 242250. [Google Scholar]
  30. Belesova K, Gasparrini A, Sie A, Sauerborn R, Wilkinson P, , 2017. Household cereal crop harvest and children’s nutritional status in rural Burkina Faso. Environ Health 16: 65. [Google Scholar]
  31. Golding N, 2017. Mapping under-5 and neonatal mortality in Africa, 2000–15: a baseline analysis for the sustainable development goals. Lancet 390: 21712182. [Google Scholar]
  32. Korpela K, Salonen A, Virta LJ, Kekkonen RA, Forslund K, Bork P, de Vos WM, , 2016. Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children. Nat Commun 7: 1041010413. [Google Scholar]
  33. Korpela K, Zijlmans MAC, Kuitunen M, Kukkonen K, Savilahti E, Salonen A, de Weerth C, de Vos WM, , 2017. Childhood BMI in relation to microbiota in infancy and lifetime antibiotic use. Microbiome 5: 26. [Google Scholar]
  34. Angelakis E, Merhej V, Raoult D, , 2013. Related actions of probiotics and antibiotics on gut microbiota and weight modification. Lancet Infect Dis 13: 889899. [Google Scholar]
  35. Page A-L, 2013. Infections in children admitted with complicated severe acute malnutrition in Niger. PLoS One 8: e68699. [Google Scholar]
  36. Padonou G, Le Port A, Cottrell G, Guerra J, Choudat I, Rachas A, Bouscaillou J, Massougbodji A, Garcia A, Martin-Prevel Y, , 2014. Factors associated with growth patterns from birth to 18 months in a Beninese cohort of children. Acta Trop 135: 19. [Google Scholar]
  37. Leo GO, MAL-ED Network Investigators , 2017. Infant nutritional status, feeding practices, enteropathogen exposure, socioeconomic status, and illness are associated with gut barrier function as assessed by the lactulose mannitol test in the MAL-ED Birth Cohort. Am J Trop Med Hyg 97: 281290. [Google Scholar]
  38. Owino V, Ahmed T, Freemark M, Kelly P, Loy A, Manary M, Loechl C, , 2016. Environmental enteric dysfunction and growth failure/stunting in global child health. Pediatrics 138: pii: e20160641. [Google Scholar]
  39. DeBoer M, Scharf RJ, Leite AM, Férrer A, Havt A, Pinkerton R, Lima AA, Guerrant RL, , 2017. Systemic inflammation, growth factors, and linear growth in the setting of infection and malnutrition. Nutrition 33: 248253. [Google Scholar]
  40. de Onis M, Branca F, , 2016. Childhood stunting: a global perspective. Matern Child Nutr 12: 1226. [Google Scholar]
  41. Briend A, Khara T, Dolan C, , 2015. Wasting and stunting—similarities and differences: policy and programmatic implications. Food Nutr Bull 36: S15S23. [Google Scholar]
  42. Prendergast A, Walker AS, Mulenga V, Chintu C, Gibb DM, , 2011. Improved growth and anemia in HIV-infected African children taking cotrimoxazole prophylaxis. Clin Infect Dis 52: 953956. [Google Scholar]
  43. Schachter J, 1999. Azithromycin in control of trachoma. Lancet 354: 630635. [Google Scholar]
  44. Solomon AW, 2004. Mass treatment with single-dose azithromycin for trachoma. N Engl J Med 351: 19621971. [Google Scholar]
  45. Chidambaram JD, 2006. Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma. JAMA 295: 11421146. [Google Scholar]
  46. Emerson PM, Hooper PJ, Sarah V, , 2017. Progress and projections in the program to eliminate trachoma. PLoS Negl Trop Dis 11: e0005402. [Google Scholar]
  47. Keenan JD, MORDOR Study Group , 2018. Mass azithromycin distribution for reducing childhood mortality in sub-Saharan Africa. N Engl J Med 378: 15831592. [Google Scholar]
  48. Matheson AI, Manhart LE, Pavlinac PB, Means AR, Akullian A, Levine GA, Jacobson J, Shutes E, Walson JL, , 2014. Prioritizing countries for interventions to reduce child mortality: tools for maximizing the impact of mass drug administration of azithromycin. PLoS One 9: e96658. [Google Scholar]
  49. Pavlinac PB, 2017. Azithromycin to prevent post-discharge morbidity and mortality in Kenyan children: a protocol for a randomised, double-blind, placebo-controlled trial (the Toto Bora trial). BMJ Open 7: e019170. [Google Scholar]
  50. Fry AM, Jha HC, Lietman TM, Chaudhary JSP, Bhatta RC, Elliott J, Hyde T, Schuchat A, Gaynor B, Dowell SF, , 2002. Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal. Clin Infect Dis 35: 395402. [Google Scholar]
  51. Gaynor BD, 2014. Impact of mass azithromycin distribution on malaria parasitemia during the low-transmission season in Niger: a cluster-randomized trial. Am J Trop Med Hyg 90: 846851. [Google Scholar]
  52. Schachterle SE, Mtove G, Levens JP, Clemens E, Shi L, Raj A, Dumler JS, Munoz B, West S, Sullivan DJ, , 2014. Short-term malaria reduction by single-dose azithromycin during mass drug administration for trachoma, Tanzania. Emerg Infect Dis 20: 19. [Google Scholar]
  53. Coles CL, Seidman JC, Levens J, Mkocha H, Munoz B, West S, , 2011. Association of mass treatment with azithromycin in trachoma-endemic communities with short-term reduced risk of diarrhea in young children. Am J Trop Med Hyg 85: 691696. [Google Scholar]
  54. Berkley JA, 2016. Daily co-trimoxazole prophylaxis to prevent mortality in children with complicated severe acute malnutrition: a multicentre, double-blind, randomised placebo-controlled trial. Lancet Glob Health 4: e464e473. [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.18-0342
Loading
/content/journals/10.4269/ajtmh.18-0342
Loading

Data & Media loading...

  • Received : 21 Apr 2018
  • Accepted : 14 Jun 2018
  • Published online : 16 Jul 2018

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error